Molecular Therapy — Methods & Clinical Development · 2015 · 82 citations · 52 references
Life SciencesGeneticsMolecular BiologyGene ExpressionGene TherapyMitochondrial BiologyMitochondrial DiseaseMitochondrial DisordersMitochondrial Gene ExpressionMitochondrial TranscriptionOcular Gene DeliveryOcular Gene TherapyCentral Vision ImpairmentCentral Visual LossLeber Hereditary Optic NeuropathyMitochondrial Dna MutationsMitochondrial Dna Point MutationsMitochondrial Gene TherapyRespiratory Chain ComplexesSustained Gene Expression
Leber hereditary optic neuropathy is due to mitochondrial DNA mutations; in ∼70% of all cases, a point mutation in the mitochondrial NADH dehydrogenase subunit 4, ND4, gene leads to central vision loss. We optimized allotopic expression (nuclear transcription of a gene that is normally transcribed inside the mitochondria) aimed at designing a gene therapy for ND4; its coding sequence was associated with the cis-acting elements of the human COX10 mRNA to allow the efficient mitochondrial delivery of the protein. After ocular administration to adult rats of a recombinant adeno-associated viral vector containing the human ND4 gene, we demonstrated that: (i) the sustained expression of human ND4 did not lead to harmful effects, instead the human protein is efficiently imported inside the mitochondria and assembled in respiratory chain complex I; (ii) the presence of the human protein in the experimental model of Leber hereditary optic neuropathy significantly prevents retinal ganglion cell degeneration and preserves both complex I function in optic nerves and visual function. Hence, the use of optimized allotopic expression is relevant for treating mitochondrial disorders due to mutations in the organelle genome. Leber hereditary optic neuropathy is due to mitochondrial DNA mutations; in ∼70% of all cases, a point mutation in the mitochondrial NADH dehydrogenase subunit 4, ND4, gene leads to central vision loss. We optimized allotopic expression (nuclear transcription of a gene that is normally transcribed inside the mitochondria) aimed at designing a gene therapy for ND4; its coding sequence was associated with the cis-acting elements of the human COX10 mRNA to allow the efficient mitochondrial delivery of the protein. After ocular administration to adult rats of a recombinant adeno-associated viral vector containing the human ND4 gene, we demonstrated that: (i) the sustained expression of human ND4 did not lead to harmful effects, instead the human protein is efficiently imported inside the mitochondria and assembled in respiratory chain complex I; (ii) the presence of the human protein in the experimental model of Leber hereditary optic neuropathy significantly prevents retinal ganglion cell degeneration and preserves both complex I function in optic nerves and visual function. Hence, the use of optimized allotopic expression is relevant for treating mitochondrial disorders due to mutations in the organelle genome.
52
Mitochondrial DNA Mutation Associated with Leber's Hereditary Optic Neuropathy
Douglas C. Wallace, Gurparkash Singh, Marie T. Lott et al. · Science · 1988 · 2.4K citations
Rolf Luft, Denis Ikkos, Genaro M. A. Palmieri et al. · Journal of Clinical Investigation · 1962 · 982 citations · Full text
Prevalence of mitochondrial DNA disease in adults
Andrew M. Schaefer, Robert McFarland, Emma L. Blakely et al. · Annals of Neurology · 2007 · 582 citations
A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy
Thomas Klopstock, Patrick Yu‐Wai‐Man, Konstantinos Dimitriadis et al. · Brain · 2011 · 569 citations · Full text
Medicine, Neurology, Ophthalmology +17